FTD commonly affects individuals under 60, causing severe cognitive issues.
CSF proteomics can identify protein patterns linked to disease progression.
Early protein changes may indicate the onset of symptoms years prior.
A focus on RNA splicing proteins was pivotal in diagnosis.
Collaborations for validation include the ALLFTD consortium.
Neurology
Omics
Neurology
Biochemistry and molecular biology
Liquid biopsy
Molecular Pathology
Insights
Latest
Profession
Caught in the Middle: Dementia in Midlife
Proteomic profiling of spinal fluid may provide the early diagnostic clarity of frontotemporal dementia in younger populations
08/11/2025
Interview
4 min read